Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors

被引:17
作者
Sato, Younosuke [1 ]
Okamoto, Isamu [2 ]
Kameyama, Hiroki [3 ]
Kudoh, Shinji [1 ]
Saito, Haruki [1 ,4 ]
Sanada, Mune [1 ,5 ]
Kudo, Noritaka [1 ]
Wakimoto, Joeji [6 ]
Fujino, Kosuke [5 ]
Ikematsu, Yuki [2 ]
Tanaka, Kentaro [2 ]
Nishikawa, Ayako [1 ]
Sakaguchi, Ryo [1 ]
Ito, Takaaki [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto 8608556, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 8128582, Japan
[3] Kumamoto Hlth Sci Univ, Fac Hlth Sci, Dept Med Examinat, Kumamoto 8615598, Japan
[4] Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, Kumamoto 8608556, Japan
[5] Kumamoto Univ, Grad Sch Med Sci, Dept Otolaryngol Head & Neck Surg, Kumamoto 8608556, Japan
[6] Natl Hosp Org Minami Kyushu Natl Hosp, Kagoshima 8995293, Japan
关键词
small-cell lung cancer; immunohistochemistry; ASCL1; NEUROD1; YAP1; NEUROENDOCRINE DIFFERENTIATION; CANCER; ASCL1; AMPLIFICATION; ESTABLISHMENT; PATHWAY; NEUROD1; TUMORS;
D O I
10.3390/diagnostics10110949
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Small-cell lung cancer (SCLC) is an aggressive malignant cancer that is classified into four subtypes based on the expression of the following key transcription and co-transcription factors: ASCL1, NEUROD1, YAP1, and POU2F3. The protein expression levels of these key molecules may be important for the formation of SCLC characteristics in a molecular subtype-specific manner. We expect that immunohistochemistry (IHC) of these molecules may facilitate the diagnosis of the specific SCLC molecular subtype and aid in the appropriate selection of individualized treatments. We attempted IHC of the four key factors and 26 candidate SCLC target molecules selected from the gene expression omnibus datasets of 47 SCLC samples, which were grouped based on positive or negative results for the four key molecules. We examined differences in the expression levels of the candidate targets and key molecules. ASCL1 showed the highest positive rate in SCLC samples, and significant differences were observed in the expression levels of some target molecules between the ASCL1-positive and ASCL1-negative groups. Furthermore, the four key molecules were coordinately and simultaneously expressed in SCLC cells. An IHC study of ASCL1-positive samples showed many candidate SCLC target molecules, and IHC could become an essential method for determining SCLC molecular subtypes.
引用
收藏
页数:14
相关论文
共 46 条
  • [1] Mutational signatures associated with tobacco smoking in human cancer
    Alexandrov, Ludmil B.
    Ju, Young Seok
    Haase, Kerstin
    Van Loo, Peter
    Martincorena, Inigo
    Nik-Zainal, Serena
    Totoki, Yasushi
    Fujimoto, Akihiro
    Nakagawa, Hidewaki
    Shibata, Tatsuhiro
    Campbell, Peter J.
    Vineis, Paolo
    Phillips, David H.
    Stratton, Michael R.
    [J]. SCIENCE, 2016, 354 (6312) : 618 - 622
  • [2] MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study
    Alves, Rita de Cassia S.
    Meurer, Rosalva Thereza
    Roehe, Adriana Vial
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (12) : 2021 - 2025
  • [3] The nature of the "oat-celled sarcoma" of the mediastinum.
    Barnard, WG
    [J]. JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1926, 29 (03): : 241 - 244
  • [4] BENSCH KG, 1968, CANCER, V22, P1163, DOI 10.1002/1097-0142(196811)22:6<1163::AID-CNCR2820220612>3.0.CO
  • [5] 2-L
  • [6] An achaete-scute homologue essential for neuroendocrine differentiation in the lung
    Borges, M
    Linnoila, RI
    vandeVelde, HJK
    Chen, H
    Nelkin, BD
    Mabry, M
    Baylin, SB
    Ball, DW
    [J]. NATURE, 1997, 386 (6627) : 852 - 855
  • [7] ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs
    Borromeo, Mark D.
    Savage, Trisha K.
    Kollipara, Rahul K.
    He, Min
    Augustyn, Alexander
    Osborne, Jihan K.
    Girard, Luc
    Minna, John D.
    Gazdar, Adi F.
    Cobb, Melanie H.
    Johnson, Jane E.
    [J]. CELL REPORTS, 2016, 16 (05): : 1259 - 1272
  • [8] CARNEY DN, 1985, CANCER RES, V45, P2913
  • [9] Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups
    Centonze, Giovanni
    Biganzoli, Davide
    Prinzi, Natalie
    Pusceddu, Sara
    Mangogna, Alessandro
    Tamborini, Elena
    Perrone, Federica
    Busico, Adele
    Lagano, Vincenzo
    Cattaneo, Laura
    Sozzi, Gabriella
    Roz, Luca
    Biganzoli, Elia
    Milione, Massimo
    [J]. CANCERS, 2020, 12 (10) : 1 - 16
  • [10] Comprehensive molecular profiling of lung adenocarcinoma
    Collisson, Eric A.
    Campbell, Joshua D.
    Brooks, Angela N.
    Berger, Alice H.
    Lee, William
    Chmielecki, Juliann
    Beer, David G.
    Cope, Leslie
    Creighton, Chad J.
    Danilova, Ludmila
    Ding, Li
    Getz, Gad
    Hammerman, Peter S.
    Hayes, D. Neil
    Hernandez, Bryan
    Herman, James G.
    Heymach, John V.
    Jurisica, Igor
    Kucherlapati, Raju
    Kwiatkowski, David
    Ladanyi, Marc
    Robertson, Gordon
    Schultz, Nikolaus
    Shen, Ronglai
    Sinha, Rileen
    Sougnez, Carrie
    Tsao, Ming-Sound
    Travis, William D.
    Weinstein, John N.
    Wigle, Dennis A.
    Wilkerson, Matthew D.
    Chu, Andy
    Cherniack, Andrew D.
    Hadjipanayis, Angela
    Rosenberg, Mara
    Weisenberger, Daniel J.
    Laird, Peter W.
    Radenbaugh, Amie
    Ma, Singer
    Stuart, Joshua M.
    Byers, Lauren Averett
    Baylin, Stephen B.
    Govindan, Ramaswamy
    Meyerson, Matthew
    Rosenberg, Mara
    Gabriel, Stacey B.
    Cibulskis, Kristian
    Sougnez, Carrie
    Kim, Jaegil
    Stewart, Chip
    [J]. NATURE, 2014, 511 (7511) : 543 - 550